Heliox
Heliox is a pharmaceutical drug with 13 clinical trials. Currently 1 active trials ongoing. Historical success rate of 90.9%.
Success Metrics
Based on 10 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
1
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
90.9%
10 of 11 finished
9.1%
1 ended early
1
trials recruiting
13
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Heliox on the Work of Breathing in Adult Patients With Lower Airway Stenosis
Limitation of the Ventilatory Response to Exercise in the Master Athlete
Effects of Non-invasive Ventilation With Helium-oxygen Mixture in Premature Infants With Respiratory Distress Syndrome
Heliox-Driven Racemic Epinephrine in Treatment of Bronchiolitis in Pediatric ED Patients
Effect of Heliox on RSV Bronchiolitis
Clinical Trials (13)
Heliox on the Work of Breathing in Adult Patients With Lower Airway Stenosis
Limitation of the Ventilatory Response to Exercise in the Master Athlete
Effects of Non-invasive Ventilation With Helium-oxygen Mixture in Premature Infants With Respiratory Distress Syndrome
Heliox-Driven Racemic Epinephrine in Treatment of Bronchiolitis in Pediatric ED Patients
Effect of Heliox on RSV Bronchiolitis
HELIox CardiOPlegia Trial During Cardiac surgERy
The Use of Heliox in Obstructive Sleep Apnea Syndrome
Innovation in Pulmonary Rehabilitation
Heliox in Preterm Infants With Respiratory Distress Syndrome
Plethysmography Opto-electronic and Asthma
Use of Heliox Associated With PEEP in Patients With Asthma
Heliox and Posture in Patients With Asthma
Heliox in Experimental Upper Airway Obstruction
All 13 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 13